Xianghong Li

Title: Innovations of Xianghong Li in Protein Targeting

Introduction

Xianghong Li is a notable inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the area of protein targeting within the genome. His work has implications for various applications in genetic engineering and therapeutic development.

Latest Patents

Xianghong Li holds a patent for "Compositions and methods for directing proteins to specific loci in the genome." This patent discloses compositions and methods that allow for the precise targeting of proteins to specific locations within an organism's genome. The methods involve providing a fusion protein that includes a DNA localization component and an effector molecule. Notable embodiments of this invention include fusion proteins such as dSaCas9-Clo051, dCas9-Clo051, TALE-Clo051, and others.

Career Highlights

Xianghong Li is currently associated with Poseida Therapeutics, Inc., where he continues to advance his research in protein targeting and genetic engineering. His innovative approaches have the potential to enhance the efficacy of gene therapies and other biotechnological applications.

Collaborations

Xianghong Li collaborates with esteemed colleagues, including Eric Michael Ostertag and Tseten Yeshi. These collaborations foster a dynamic research environment that promotes the development of cutting-edge biotechnological solutions.

Conclusion

Xianghong Li's contributions to the field of protein targeting represent a significant advancement in biotechnology. His innovative patent and ongoing work at Poseida Therapeutics, Inc. highlight his role as a leading inventor in this critical area of research.